Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc J Claeys

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Basic Research in Cardiology|October 28, 2009
Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?Viviane M Conraads, Christiaan J Vrints, Inez E Rodrigus, et al.
Journal of the American College of Cardiology|July 2, 2016
Mechanism of Symptomatic Improvement After Percutaneous Therapy for Secondary Mitral Regurgitation: Resting and Exercise HemodynamicsCaroline M Van De Heyning, Philippe B Bertrand, Philippe Debonnaire, et al.
Acta Cardiologica|July 18, 2014
Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in BelgiumTom Vandendriessche, Martin Kotrc, Maxime Tijskens, et al.
The Canadian Journal of Cardiology|December 25, 2013
Levels of circulating CD34+/KDR+ cells do not predict coronary in-stent restenosisSteven E Haine, Emeline M Van Craenenbroeck, Vicky Y Hoymans, et al.
The American Journal of Cardiology|January 17, 2021
Effect of Mitral Regurgitation on Thrombotic Risk in Patients With Nonrheumatic Atrial Fibrillation: A New CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Risk Modifier?Sven L Van Laer, Seppe Verreyen, Koen M Winkler, et al.
Archives of Internal Medicine|March 30, 2011
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarctionMarc J Claeys, Antoine de Meester, Carl Convens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 6, 2012
Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantationAnne Vorlat, Viviane M Conraads, Philippe G Jorens, et al.
The American Journal of Cardiology|May 2, 2015
Usefulness of early rule-in and rule-out biomarker protocols to estimate ischemia-induced myocardial injury in early chest pain presentersAnne Vorlat, Viviane O Van Hoof, Rania Hammami, et al.
Transplantation Proceedings|July 17, 2019
Biomarkers and Donor Selection in Heart TransplantationAnne Vorlat, Nicolas De Hous, Alexander J Vervaecke, et al.
European Heart Journal. Acute Cardiovascular Care|February 28, 2015
Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarctionLynn De Roeck, Sarah Vandamme, Bert R Everaert, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Basic Research in Cardiology|October 28, 2009
Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?Viviane M Conraads, Christiaan J Vrints, Inez E Rodrigus, et al.
Journal of the American College of Cardiology|July 2, 2016
Mechanism of Symptomatic Improvement After Percutaneous Therapy for Secondary Mitral Regurgitation: Resting and Exercise HemodynamicsCaroline M Van De Heyning, Philippe B Bertrand, Philippe Debonnaire, et al.
Acta Cardiologica|July 18, 2014
Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in BelgiumTom Vandendriessche, Martin Kotrc, Maxime Tijskens, et al.
The Canadian Journal of Cardiology|December 25, 2013
Levels of circulating CD34+/KDR+ cells do not predict coronary in-stent restenosisSteven E Haine, Emeline M Van Craenenbroeck, Vicky Y Hoymans, et al.
The American Journal of Cardiology|January 17, 2021
Effect of Mitral Regurgitation on Thrombotic Risk in Patients With Nonrheumatic Atrial Fibrillation: A New CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Risk Modifier?Sven L Van Laer, Seppe Verreyen, Koen M Winkler, et al.
Archives of Internal Medicine|March 30, 2011
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarctionMarc J Claeys, Antoine de Meester, Carl Convens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 6, 2012
Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantationAnne Vorlat, Viviane M Conraads, Philippe G Jorens, et al.
The American Journal of Cardiology|May 2, 2015
Usefulness of early rule-in and rule-out biomarker protocols to estimate ischemia-induced myocardial injury in early chest pain presentersAnne Vorlat, Viviane O Van Hoof, Rania Hammami, et al.
Transplantation Proceedings|July 17, 2019
Biomarkers and Donor Selection in Heart TransplantationAnne Vorlat, Nicolas De Hous, Alexander J Vervaecke, et al.
European Heart Journal. Acute Cardiovascular Care|February 28, 2015
Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarctionLynn De Roeck, Sarah Vandamme, Bert R Everaert, et al.
Pageof 12